High multidrug resistance in urinary tract infections in a tertiary hospital, Kathmandu, Nepal
Public Health Action · 2021-11 · 11 (Supplement 1) · 24-31
DOI: 10.5588/pha.21.0035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health Action, online erschienen am 01.11.2021. Verfasst von S Shakya und 9 weiteren Autor:innen. Beteiligte Einrichtung: Central Department of Public Health, Tribhuvan University, Institute of Medicine, Kathmandu, Nepal. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 3 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization.
Abstract (Originalsprache)
SETTING: Tribhuvan University Teaching Tertiary Care Hospital, Kathmandu, Nepal, May–October 2019. OBJECTIVE: 1) To describe the bacteriological profile, 2) to identify the antimicrobial resistance (AMR) pattern, and 3) to find the demographic characteristics associated with the presence of bacterial growth and multidrug resistance (MDR) in adult urine samples undergoing culture and drug susceptibility testing. DESIGN: This was a hospital-based, cross-sectional study using routine laboratory records. RESULTS: Among 11,776 urine samples, 16% (1,865/11,776) were culture-positive, predominantly caused by Escherichia coli (1,159/1,865; 62%). We found a high prevalence of resistance to at least one antibiotic (1,573/1,865; 84%) and MDR (1,000/1,865; 54%). Resistance to commonly used antibiotics for urinary tract infections (UTIs) such as ceftazidime, levofloxacin, cefepime and ampicillin was high. Patients aged 60 years (adjusted prevalence ratio [aPR] 1.6, 95% CI 1.4–1.7) were more likely to have culture positivity. Patients with age 45 years (45–59 years: aPR 1.5, 95% CI 1.3–1.7; 60 years: aPR 1.4, 95% CI 1.2–1.6), male sex (aPR 1.3, 95% CI 1.2–1.5) and from inpatient settings (aPR 1.4, 95% CI 1.2–1.7) had significantly higher prevalence of MDR. CONCLUSION: Urine samples from a tertiary hospital showed high prevalence of E. coli and MDR to routinely used antibiotics, especially among inpatients. Regular surveillance and application of updated antibiograms are crucial to monitor the AMR situation in Nepal.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Central Department of Public Health, Tribhuvan University, Institute of Medicine, Kathmandu, Nepal.
- Department of Global Health, University of Washington, Seattle, WA, USA.
- Narotam Sekhsaria Foundation, Mumbai, India.
- World Health Emergencies Programme, WHO Country Office, Kathmandu, Nepal.
- Department of Anaesthesiology, Maharajgunj Medical Campus, Tribhuvan University, Institute of Medicine, Kathmandu, Nepal.
- Department of Clinical Microbiology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Förderung
- World Health Organization
Zitieren
APA
Shakya, S., Edwards, J., Gupte, H. A., Shrestha, S., Shakya, B. M., Parajuli, K., Kattel, H. P., Shrestha, P. S., Ghimire, R., & Thekkur, P. (2021). High multidrug resistance in urinary tract infections in a tertiary hospital, Kathmandu, Nepal. Public Health Action, 11(Supplement 1), 24-31. https://doi.org/10.5588/pha.21.0035
Vancouver
Shakya S, Edwards J, Gupte HA, Shrestha S, Shakya BM, Parajuli K, et al. High multidrug resistance in urinary tract infections in a tertiary hospital, Kathmandu, Nepal. Public Health Action. 2021;11(Supplement 1):24-31. doi:10.5588/pha.21.0035
BibTeX
@article{Shakya2021,
author = {Shakya, S and Edwards, J and Gupte, H A and Shrestha, S and Shakya, B M and Parajuli, K and Kattel, H P and Shrestha, P S and Ghimire, R and Thekkur, P},
title = {High multidrug resistance in urinary tract infections in a tertiary hospital, Kathmandu, Nepal},
journal = {Public Health Action},
year = {2021},
volume = {11},
number = {Supplement 1},
pages = {24--31},
doi = {10.5588/pha.21.0035}
}
EUVIMED